Role of Cost-Sharing Subsidies on the Initiation of and Adherence to Tyrosine Kinase Inhibitor Therapy by Medicare Beneficiaries with Chronic Myeloid Leukemia
Journal of Clinical Oncology. May 20 2017;35(15):1744-1745